In re Entresto (Sacubitril/Valsartan) Patent Litigation – Entresto® (Sacubitril/Valsartan)

Case Name: In re Entresto (Sacubitril/Valsartan) Patent Litigation, C.A. Nos. 19-1979, 19-2021, 19-2053, 2023 WL 4405464 (D. Del. July 7, 2023) (Andrews, J.) – Drug Product and Patent(s)-in-Suit: Entresto® (sacubitril/valsartan); U.S. Patent No. 8,101,659 (“the ’659 patent”)….
By: Robins Kaplan LLP
Previous Story

Indigo Sky Casino Notifies Guests and Employees of Recent Data Breach

Next Story

Managing Third-Party Risk: Strategies for 2024 and Beyond